Stock Analiz

Core Scientific, Inc. (CORZ) financials: revenue, earnings and cash flow

Fiscal 2020–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Core Scientific’s revenue went from $60M in fiscal 2020 to $319M in fiscal 2025, growth of about 39.5% a year.

Net income in fiscal 2025 was -$289M, a net margin of -90.5%; the best year in this period was 2021 with $47M.

Over the twelve months to September 30, 2026, revenue was $592M and net income -$111M.

Free cash flow was -$451M in fiscal 2025 and positive in 1 of the 6 years shown.

The diluted share count rose 102% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2020: $60M20202021: $544M20212022: $640M20222023: $502M20232024: $511M20242025: $319M2025$319M
Net income
2020: -$12M20202021: $47M20212022: -$2.1B20222023: -$246M20232024: -$1.4B20242025: -$289M2025-$289M
Free cash flow
2020: -$24M20202021: -$57M20212022: -$179M20222023: $49M20232024: -$52M20242025: -$451M2025-$451M
EPS (diluted)
2020: $-0.1420202021: $0.2020212022: $-6.3020222023: $-0.6520232024: $-4.8720242025: $-0.882025$-0.88

Income statement

Fiscal yearTTM202520242023202220212020
Revenue$592M$319M$511M$502M$640M$544M$60M
Gross profit$244M$38M$121M$123M$8M$239M$9M
Operating income-$434M-$246M-$142M$9M-$2.1B$131M-$6M
Net income-$111M-$289M-$1.4B-$246M-$2.1B$47M-$12M
EPS (diluted)$-0.33$-0.88$-4.87$-0.65$-6.30$0.20$-0.14
R&D——$12M$7M$27M$8M$5M
Revenue growth—−37.5%+1.7%−21.5%+17.6%+802.7%—

Cash flow

Fiscal yearTTM202520242023202220212020
Operating cash flow$454M$278M$43M$65M$205M-$57M-$24M
Capital spending-$1.8B-$729M-$95M-$16M-$384M$0$0
Free cash flow-$1.3B-$451M-$52M$49M-$179M-$57M-$24M
Dividends paid—$0$0$0$0$0$0
Buybacks——$0$0$32M——
Stock-based pay$89M$98M$52M$59M$183M$39M$3M

Balance sheet

Fiscal yearTTM202520242023202220212020
Cash—$311M$836M$50M$16M$118M$9M
Debt—$1.2B$1.2B$810M$38M$730M—
Equity—-$963M-$943M-$597M-$409M$1.3B$0
Total assets—$2.3B$1.5B$712M$808M$2.4B$15000
Shares (diluted)324M318M256M380M341M233M158M

Margins and returns

Fiscal yearTTM202520242023202220212020
Gross margin41.2%11.9%23.7%24.6%1.3%43.9%15.6%
Operating margin-73.3%-77.0%-27.8%1.8%-329.5%24.1%-10.5%
Net margin-18.8%-90.5%-281.6%-49.1%-335.2%8.7%-20.2%
FCF margin-223.0%-141.3%-10.2%9.7%-27.9%-10.4%-39.4%
ROIC—-97.5%-44.0%3.3%—4.8%—
ROE—30.0%152.5%41.3%524.3%3.5%—

Frequently asked questions

What is Core Scientific’s annual revenue?

$319M in fiscal 2025 and $592M over the twelve months to September 30, 2026.

How much profit does Core Scientific make?

Net income was -$289M in fiscal 2025 (net margin -90.5%).

Is Core Scientific’s revenue growing?

No: revenue fell 37.5% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.